▶ 調査レポート

免疫チェックポイントインヒビターの世界市場2018

• 英文タイトル:Global Immune Checkpoint Inhibitors Sales Market Report 2018

QYResearchが調査・発行した産業分析レポートです。免疫チェックポイントインヒビターの世界市場2018 / Global Immune Checkpoint Inhibitors Sales Market Report 2018 / D111336資料のイメージです。• レポートコード:D111336
• 出版社/出版日:QYResearch / 2018年10月
• レポート形態:英文、PDF、114ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User License¥424,000 (USD4,000)▷ お問い合わせ
  Enterprise License¥848,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、免疫チェックポイントインヒビターの世界市場について調査・分析し、免疫チェックポイントインヒビターのメーカー別販売量、市場シェア分析、種類別販売分析(PD-1/PD-L1、CTLA-4)、用途別販売分析(肺がん、大腸がん、乳がん、前立腺がん、黒色腫、その他)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、免疫チェックポイントインヒビター産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・免疫チェックポイントインヒビター市場概要
・免疫チェックポイントインヒビターのメーカー別販売量・メーカー別シェア
・免疫チェックポイントインヒビターの世界市場:種類別販売量(PD-1/PD-L1、CTLA-4)
・免疫チェックポイントインヒビターの世界市場:用途別販売量(肺がん、大腸がん、乳がん、前立腺がん、黒色腫、その他)
・免疫チェックポイントインヒビターの世界市場:地域別販売量・市場シェア
・免疫チェックポイントインヒビターの米国市場規模
・免疫チェックポイントインヒビターの中国市場規模
・免疫チェックポイントインヒビターの欧州市場規模
・免疫チェックポイントインヒビターの日本市場規模
・免疫チェックポイントインヒビターの東南アジア市場規模
・免疫チェックポイントインヒビターのインド市場規模
・免疫チェックポイントインヒビターのメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・免疫チェックポイントインヒビターのコスト分析・価格動向
・免疫チェックポイントインヒビターの産業チェーン(サプライチェーン分析)
・免疫チェックポイントインヒビターのマーケティング戦略・販売チャネル、流通業者
・免疫チェックポイントインヒビター市場への影響要因分析
・免疫チェックポイントインヒビターの世界市場予測
・免疫チェックポイントインヒビターの米国市場予測
・免疫チェックポイントインヒビターの中国市場予測
・免疫チェックポイントインヒビターの欧州市場予測
・免疫チェックポイントインヒビターの日本市場予測
・免疫チェックポイントインヒビターの東南アジア市場予測
・免疫チェックポイントインヒビターのインド市場予測
・免疫チェックポイントインヒビターの種類別世界市場予測(PD-1/PD-L1、CTLA-4)
・免疫チェックポイントインヒビターの用途別世界市場予測(肺がん、大腸がん、乳がん、前立腺がん、黒色腫、その他)
...

This report studies the global Immune Checkpoint Inhibitors market status and forecast, categorizes the global Immune Checkpoint Inhibitors market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
The global Immune Checkpoint Inhibitors market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major players covered in this report
Bristol Myer Squibb
AstraZeneca
Merck & Co.
Roche / Genentech
Incyte Corporation
NewLink Genetics
ArGEN-X
Seattle Genetics
Pfizer
MacroGenics
Celldex Therapeutics
CureTech
Immutep
Innate Pharma
Sorrento Therapeutics
GlaxoSmithKline
GITR, Inc

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
PD-1/PD-L1
CTLA-4
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Lung Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Melanoma
Blood Cancer
Other

The study objectives of this report are:
To analyze and study the global Immune Checkpoint Inhibitors sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Immune Checkpoint Inhibitors players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Immune Checkpoint Inhibitors are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Immune Checkpoint Inhibitors Manufacturers
Immune Checkpoint Inhibitors Distributors/Traders/Wholesalers
Immune Checkpoint Inhibitors Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Immune Checkpoint Inhibitors market, by end-use.
Detailed analysis and profiles of additional market players.

レポート目次

Table of Contents

Global Immune Checkpoint Inhibitors Sales Market Report 2018
1 Immune Checkpoint Inhibitors Market Overview
1.1 Product Overview and Scope of Immune Checkpoint Inhibitors
1.2 Classification of Immune Checkpoint Inhibitors by Product Category
1.2.1 Global Immune Checkpoint Inhibitors Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Immune Checkpoint Inhibitors Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 PD-1/PD-L1
1.2.4 CTLA-4
1.3 Global Immune Checkpoint Inhibitors Market by Application/End Users
1.3.1 Global Immune Checkpoint Inhibitors Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Lung Cancer
1.3.2 Colorectal Cancer
1.3.3 Breast Cancer
1.3.4 Prostate Cancer
1.3.5 Melanoma
1.3.6 Blood Cancer
1.3.7 Other
1.4 Global Immune Checkpoint Inhibitors Market by Region
1.4.1 Global Immune Checkpoint Inhibitors Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Immune Checkpoint Inhibitors Status and Prospect (2013-2025)
1.4.3 Europe Immune Checkpoint Inhibitors Status and Prospect (2013-2025)
1.4.4 China Immune Checkpoint Inhibitors Status and Prospect (2013-2025)
1.4.5 Japan Immune Checkpoint Inhibitors Status and Prospect (2013-2025)
1.4.6 Southeast Asia Immune Checkpoint Inhibitors Status and Prospect (2013-2025)
1.4.7 India Immune Checkpoint Inhibitors Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Immune Checkpoint Inhibitors (2013-2025)
1.5.1 Global Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2025)
1.5.2 Global Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2025)

2 Global Immune Checkpoint Inhibitors Competition by Players/Suppliers, Type and Application
2.1 Global Immune Checkpoint Inhibitors Market Competition by Players/Suppliers
2.1.1 Global Immune Checkpoint Inhibitors Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Immune Checkpoint Inhibitors Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Immune Checkpoint Inhibitors (Volume and Value) by Type
2.2.1 Global Immune Checkpoint Inhibitors Sales and Market Share by Type (2013-2018)
2.2.2 Global Immune Checkpoint Inhibitors Revenue and Market Share by Type (2013-2018)
2.3 Global Immune Checkpoint Inhibitors (Volume and Value) by Region
2.3.1 Global Immune Checkpoint Inhibitors Sales and Market Share by Region (2013-2018)
2.3.2 Global Immune Checkpoint Inhibitors Revenue and Market Share by Region (2013-2018)
2.4 Global Immune Checkpoint Inhibitors (Volume) by Application

3 United States Immune Checkpoint Inhibitors (Volume, Value and Sales Price)
3.1 United States Immune Checkpoint Inhibitors Sales and Value (2013-2018)
3.1.1 United States Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018)
3.1.2 United States Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018)
3.1.3 United States Immune Checkpoint Inhibitors Sales Price Trend (2013-2018)
3.2 United States Immune Checkpoint Inhibitors Sales Volume and Market Share by Players (2013-2018)
3.3 United States Immune Checkpoint Inhibitors Sales Volume and Market Share by Type (2013-2018)
3.4 United States Immune Checkpoint Inhibitors Sales Volume and Market Share by Application (2013-2018)

4 Europe Immune Checkpoint Inhibitors (Volume, Value and Sales Price)
4.1 Europe Immune Checkpoint Inhibitors Sales and Value (2013-2018)
4.1.1 Europe Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018)
4.1.2 Europe Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018)
4.1.3 Europe Immune Checkpoint Inhibitors Sales Price Trend (2013-2018)
4.2 Europe Immune Checkpoint Inhibitors Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Immune Checkpoint Inhibitors Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Immune Checkpoint Inhibitors Sales Volume and Market Share by Application (2013-2018)

5 China Immune Checkpoint Inhibitors (Volume, Value and Sales Price)
5.1 China Immune Checkpoint Inhibitors Sales and Value (2013-2018)
5.1.1 China Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018)
5.1.2 China Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018)
5.1.3 China Immune Checkpoint Inhibitors Sales Price Trend (2013-2018)
5.2 China Immune Checkpoint Inhibitors Sales Volume and Market Share by Players (2013-2018)
5.3 China Immune Checkpoint Inhibitors Sales Volume and Market Share by Type (2013-2018)
5.4 China Immune Checkpoint Inhibitors Sales Volume and Market Share by Application (2013-2018)

6 Japan Immune Checkpoint Inhibitors (Volume, Value and Sales Price)
6.1 Japan Immune Checkpoint Inhibitors Sales and Value (2013-2018)
6.1.1 Japan Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018)
6.1.2 Japan Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018)
6.1.3 Japan Immune Checkpoint Inhibitors Sales Price Trend (2013-2018)
6.2 Japan Immune Checkpoint Inhibitors Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Immune Checkpoint Inhibitors Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Immune Checkpoint Inhibitors Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Immune Checkpoint Inhibitors (Volume, Value and Sales Price)
7.1 Southeast Asia Immune Checkpoint Inhibitors Sales and Value (2013-2018)
7.1.1 Southeast Asia Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Immune Checkpoint Inhibitors Sales Price Trend (2013-2018)
7.2 Southeast Asia Immune Checkpoint Inhibitors Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Immune Checkpoint Inhibitors Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Immune Checkpoint Inhibitors Sales Volume and Market Share by Application (2013-2018)

8 India Immune Checkpoint Inhibitors (Volume, Value and Sales Price)
8.1 India Immune Checkpoint Inhibitors Sales and Value (2013-2018)
8.1.1 India Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018)
8.1.2 India Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018)
8.1.3 India Immune Checkpoint Inhibitors Sales Price Trend (2013-2018)
8.2 India Immune Checkpoint Inhibitors Sales Volume and Market Share by Players (2013-2018)
8.3 India Immune Checkpoint Inhibitors Sales Volume and Market Share by Type (2013-2018)
8.4 India Immune Checkpoint Inhibitors Sales Volume and Market Share by Application (2013-2018)

9 Global Immune Checkpoint Inhibitors Players/Suppliers Profiles and Sales Data
9.1 Bristol Myer Squibb
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Bristol Myer Squibb Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 AstraZeneca
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 AstraZeneca Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Merck & Co.
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Merck & Co. Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Roche / Genentech
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Roche / Genentech Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Incyte Corporation
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Incyte Corporation Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 NewLink Genetics
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 NewLink Genetics Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 ArGEN-X
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 ArGEN-X Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Seattle Genetics
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Seattle Genetics Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Pfizer
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Pfizer Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 MacroGenics
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 MacroGenics Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Celldex Therapeutics
9.12 CureTech
9.13 Immutep
9.14 Innate Pharma
9.15 Sorrento Therapeutics
9.16 GlaxoSmithKline
9.17 GITR, Inc

10 Immune Checkpoint Inhibitors Maufacturing Cost Analysis
10.1 Immune Checkpoint Inhibitors Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Immune Checkpoint Inhibitors
10.3 Manufacturing Process Analysis of Immune Checkpoint Inhibitors

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Immune Checkpoint Inhibitors Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Immune Checkpoint Inhibitors Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Immune Checkpoint Inhibitors Market Forecast (2018-2025)
14.1 Global Immune Checkpoint Inhibitors Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Immune Checkpoint Inhibitors Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Immune Checkpoint Inhibitors Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Immune Checkpoint Inhibitors Price and Trend Forecast (2018-2025)
14.2 Global Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Immune Checkpoint Inhibitors Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Immune Checkpoint Inhibitors Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Immune Checkpoint Inhibitors Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Immune Checkpoint Inhibitors Sales Forecast by Type (2018-2025)
14.3.2 Global Immune Checkpoint Inhibitors Revenue Forecast by Type (2018-2025)
14.3.3 Global Immune Checkpoint Inhibitors Price Forecast by Type (2018-2025)
14.4 Global Immune Checkpoint Inhibitors Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Immune Checkpoint Inhibitors
Figure Global Immune Checkpoint Inhibitors Sales Volume Comparison (K Pcs) by Type (2013-2025)
Figure Global Immune Checkpoint Inhibitors Sales Volume Market Share by Type (Product Category) in 2017
Figure PD-1/PD-L1 Product Picture
Figure CTLA-4 Product Picture
Figure Global Immune Checkpoint Inhibitors Sales Comparison (K Pcs) by Application (2013-2025)
Figure Global Sales Market Share of Immune Checkpoint Inhibitors by Application in 2017
Figure Lung Cancer Examples
Table Key Downstream Customer in Lung Cancer
Figure Colorectal Cancer Examples
Table Key Downstream Customer in Colorectal Cancer
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Prostate Cancer Examples
Table Key Downstream Customer in Prostate Cancer
Figure Melanoma Examples
Table Key Downstream Customer in Melanoma
Figure Blood Cancer Examples
Table Key Downstream Customer in Blood Cancer
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Immune Checkpoint Inhibitors Market Size (Million USD) by Regions (2013-2025)
Figure United States Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Global Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Immune Checkpoint Inhibitors Sales Volume (K Pcs) (2013-2018)
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Global Immune Checkpoint Inhibitors Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Immune Checkpoint Inhibitors Sales Share by Players/Suppliers
Figure 2017 Immune Checkpoint Inhibitors Sales Share by Players/Suppliers
Figure Global Immune Checkpoint Inhibitors Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Immune Checkpoint Inhibitors Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Immune Checkpoint Inhibitors Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Immune Checkpoint Inhibitors Revenue Share by Players
Table 2017 Global Immune Checkpoint Inhibitors Revenue Share by Players
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) and Market Share by Type (2013-2018)
Table Global Immune Checkpoint Inhibitors Sales Share (K Pcs) by Type (2013-2018)
Figure Sales Market Share of Immune Checkpoint Inhibitors by Type (2013-2018)
Figure Global Immune Checkpoint Inhibitors Sales Growth Rate by Type (2013-2018)
Table Global Immune Checkpoint Inhibitors Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Immune Checkpoint Inhibitors Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Immune Checkpoint Inhibitors by Type (2013-2018)
Figure Global Immune Checkpoint Inhibitors Revenue Growth Rate by Type (2013-2018)
Table Global Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Global Immune Checkpoint Inhibitors Sales Share by Region (2013-2018)
Figure Sales Market Share of Immune Checkpoint Inhibitors by Region (2013-2018)
Figure Global Immune Checkpoint Inhibitors Sales Growth Rate by Region in 2017
Table Global Immune Checkpoint Inhibitors Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Immune Checkpoint Inhibitors Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Immune Checkpoint Inhibitors by Region (2013-2018)
Figure Global Immune Checkpoint Inhibitors Revenue Growth Rate by Region in 2017
Table Global Immune Checkpoint Inhibitors Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Immune Checkpoint Inhibitors Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Immune Checkpoint Inhibitors by Region (2013-2018)
Figure Global Immune Checkpoint Inhibitors Revenue Market Share by Region in 2017
Table Global Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Global Immune Checkpoint Inhibitors Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Immune Checkpoint Inhibitors by Application (2013-2018)
Figure Global Immune Checkpoint Inhibitors Sales Market Share by Application (2013-2018)
Figure United States Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (2013-2018)
Figure United States Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Immune Checkpoint Inhibitors Sales Price (USD/Pcs) Trend (2013-2018)
Table United States Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Players (2013-2018)
Table United States Immune Checkpoint Inhibitors Sales Volume Market Share by Players (2013-2018)
Figure United States Immune Checkpoint Inhibitors Sales Volume Market Share by Players in 2017
Table United States Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Type (2013-2018)
Table United States Immune Checkpoint Inhibitors Sales Volume Market Share by Type (2013-2018)
Figure United States Immune Checkpoint Inhibitors Sales Volume Market Share by Type in 2017
Table United States Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Application (2013-2018)
Table United States Immune Checkpoint Inhibitors Sales Volume Market Share by Application (2013-2018)
Figure United States Immune Checkpoint Inhibitors Sales Volume Market Share by Application in 2017
Figure Europe Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Immune Checkpoint Inhibitors Sales Price (USD/Pcs) Trend (2013-2018)
Table Europe Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Players (2013-2018)
Table Europe Immune Checkpoint Inhibitors Sales Volume Market Share by Players (2013-2018)
Figure Europe Immune Checkpoint Inhibitors Sales Volume Market Share by Players in 2017
Table Europe Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Type (2013-2018)
Table Europe Immune Checkpoint Inhibitors Sales Volume Market Share by Type (2013-2018)
Figure Europe Immune Checkpoint Inhibitors Sales Volume Market Share by Type in 2017
Table Europe Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Application (2013-2018)
Table Europe Immune Checkpoint Inhibitors Sales Volume Market Share by Application (2013-2018)
Figure Europe Immune Checkpoint Inhibitors Sales Volume Market Share by Application in 2017
Figure China Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Immune Checkpoint Inhibitors Sales Price (USD/Pcs) Trend (2013-2018)
Table China Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Players (2013-2018)
Table China Immune Checkpoint Inhibitors Sales Volume Market Share by Players (2013-2018)
Figure China Immune Checkpoint Inhibitors Sales Volume Market Share by Players in 2017
Table China Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Type (2013-2018)
Table China Immune Checkpoint Inhibitors Sales Volume Market Share by Type (2013-2018)
Figure China Immune Checkpoint Inhibitors Sales Volume Market Share by Type in 2017
Table China Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Application (2013-2018)
Table China Immune Checkpoint Inhibitors Sales Volume Market Share by Application (2013-2018)
Figure China Immune Checkpoint Inhibitors Sales Volume Market Share by Application in 2017
Figure Japan Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Immune Checkpoint Inhibitors Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Players (2013-2018)
Table Japan Immune Checkpoint Inhibitors Sales Volume Market Share by Players (2013-2018)
Figure Japan Immune Checkpoint Inhibitors Sales Volume Market Share by Players in 2017
Table Japan Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Immune Checkpoint Inhibitors Sales Volume Market Share by Type (2013-2018)
Figure Japan Immune Checkpoint Inhibitors Sales Volume Market Share by Type in 2017
Table Japan Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Application (2013-2018)
Table Japan Immune Checkpoint Inhibitors Sales Volume Market Share by Application (2013-2018)
Figure Japan Immune Checkpoint Inhibitors Sales Volume Market Share by Application in 2017
Figure Southeast Asia Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Immune Checkpoint Inhibitors Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Players (2013-2018)
Table Southeast Asia Immune Checkpoint Inhibitors Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Immune Checkpoint Inhibitors Sales Volume Market Share by Players in 2017
Table Southeast Asia Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Immune Checkpoint Inhibitors Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Immune Checkpoint Inhibitors Sales Volume Market Share by Type in 2017
Table Southeast Asia Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Application (2013-2018)
Table Southeast Asia Immune Checkpoint Inhibitors Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Immune Checkpoint Inhibitors Sales Volume Market Share by Application in 2017
Figure India Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Immune Checkpoint Inhibitors Sales Price (USD/Pcs) Trend (2013-2018)
Table India Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Players (2013-2018)
Table India Immune Checkpoint Inhibitors Sales Volume Market Share by Players (2013-2018)
Figure India Immune Checkpoint Inhibitors Sales Volume Market Share by Players in 2017
Table India Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Type (2013-2018)
Table India Immune Checkpoint Inhibitors Sales Volume Market Share by Type (2013-2018)
Figure India Immune Checkpoint Inhibitors Sales Volume Market Share by Type in 2017
Table India Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Application (2013-2018)
Table India Immune Checkpoint Inhibitors Sales Volume Market Share by Application (2013-2018)
Figure India Immune Checkpoint Inhibitors Sales Volume Market Share by Application in 2017
Table Bristol Myer Squibb Basic Information List
Table Bristol Myer Squibb Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bristol Myer Squibb Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure Bristol Myer Squibb Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018)
Figure Bristol Myer Squibb Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AstraZeneca Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure AstraZeneca Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018)
Figure AstraZeneca Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table Merck & Co. Basic Information List
Table Merck & Co. Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck & Co. Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure Merck & Co. Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018
Figure Merck & Co. Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table Roche / Genentech Basic Information List
Table Roche / Genentech Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Roche / Genentech Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure Roche / Genentech Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018)
Figure Roche / Genentech Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table Incyte Corporation Basic Information List
Table Incyte Corporation Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Incyte Corporation Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure Incyte Corporation Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018)
Figure Incyte Corporation Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table NewLink Genetics Basic Information List
Table NewLink Genetics Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure NewLink Genetics Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure NewLink Genetics Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018
Figure NewLink Genetics Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table ArGEN-X Basic Information List
Table ArGEN-X Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure ArGEN-X Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure ArGEN-X Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018)
Figure ArGEN-X Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Seattle Genetics Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure Seattle Genetics Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018
Figure Seattle Genetics Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pfizer Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure Pfizer Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018)
Figure Pfizer Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table MacroGenics Basic Information List
Table MacroGenics Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure MacroGenics Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure MacroGenics Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018)
Figure MacroGenics Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table Celldex Therapeutics Basic Information List
Table CureTech Basic Information List
Table Immutep Basic Information List
Table Innate Pharma Basic Information List
Table Sorrento Therapeutics Basic Information List
Table GlaxoSmithKline Basic Information List
Table GITR, Inc Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immune Checkpoint Inhibitors
Figure Manufacturing Process Analysis of Immune Checkpoint Inhibitors
Figure Immune Checkpoint Inhibitors Industrial Chain Analysis
Table Raw Materials Sources of Immune Checkpoint Inhibitors Major Players in 2017
Table Major Buyers of Immune Checkpoint Inhibitors
Table Distributors/Traders List
Figure Global Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Immune Checkpoint Inhibitors Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Global Immune Checkpoint Inhibitors Sales Volume (K Pcs) Forecast by Regions (2018-2025)
Figure Global Immune Checkpoint Inhibitors Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Immune Checkpoint Inhibitors Sales Volume Market Share Forecast by Regions in 2025
Table Global Immune Checkpoint Inhibitors Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Immune Checkpoint Inhibitors Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Immune Checkpoint Inhibitors Revenue Market Share Forecast by Regions in 2025
Figure United States Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Immune Checkpoint Inhibitors Revenue and Growth Rate Forecast (2018-2025)
Figure China Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) Forecast by Type (2018-2025)
Figure Global Immune Checkpoint Inhibitors Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Immune Checkpoint Inhibitors Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Immune Checkpoint Inhibitors Revenue Market Share Forecast by Type (2018-2025)
Table Global Immune Checkpoint Inhibitors Price (USD/Pcs) Forecast by Type (2018-2025)
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Immune Checkpoint Inhibitors Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources